The Nevada National Board Professional Learning Institute | Atkins | Activity http://www.nationalboardinstitute.com/members/shrimpoval34/activity/ Activity feed for Atkins. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 88ced105f32a177999c2a995503a653a Atkins posted an update: The current study provides initial evidence that perceived […] http://www.nationalboardinstitute.com/activity/p/42645/ Sun, 09 Feb 2025 10:28:13 -0800 The current study provides initial evidence that perceived social support provides protection for lonely people in daily life as well as during unexpected disasters, which will contribute to finding ways to alleviate lonely people’s anxiety during this global health crisis.

Since the spread of COVID-19 on a global scale, most of efforts at…[Read more]

]]> 0 84d51da1914d85b1c539f4a1b4288139 Atkins posted an update: Finally, BSEM showed that these two factors labelled […] http://www.nationalboardinstitute.com/activity/p/41707/ Sat, 08 Feb 2025 10:25:10 -0800 Finally, BSEM showed that these two factors labelled ‘sensory capability’ and ‘information integration’ independently explained cognitive status. We conclude that sensory decline and enhanced information integration might relate to distinct processes of ageing and discuss a potential role of the parietal cortex in mediating augmented integration…[Read more]

]]> 0 c67a8607701f143597c8881e37e03282 Atkins posted an update: The degree to which the EU version of Juul with 20mg/ml […] http://www.nationalboardinstitute.com/activity/p/38254/ Tue, 04 Feb 2025 10:29:33 -0800 The degree to which the EU version of Juul with 20mg/ml nicotine (Juul EU) delivers nicotine to users is likely to determine its treatment potential.

To compare the pharmacokinetic profile and user ratings of Juul EU, Juul US (59mg/ml nicotine), cigarettes and other e-cigarette (EC) products.

In a within-subjects crossover design,…[Read more]

]]> 0 4fa74472d4b9b0f2797a6ec124e9b0af Atkins posted an update: The data are not often replicated and most of the studies […] http://www.nationalboardinstitute.com/activity/p/36464/ Sun, 02 Feb 2025 10:35:09 -0800 The data are not often replicated and most of the studies focus on different treatments, so that it is difficult to compare them.

The presence of BPD seems to hamper the achievement of symptom remission in MDD patients, while the combination of selective serotonin reuptake inhibitors (SSRI) and psychotherapy may represent a valid option to…[Read more]

]]> 0 52f3e4a66a6ac88bb50706dca59581c5 Atkins posted an update: = 0.597, s.e. = 0.096, p < 0.001; higher weight, est. = […] http://www.nationalboardinstitute.com/activity/p/33753/ Thu, 30 Jan 2025 10:34:28 -0800 = 0.597, s.e. = 0.096, p < 0.001; higher weight, est. = 0.495, s.e. = 0.83, p < 0.001), but not at follow-up. Neuronal Signaling inhibitor There were no differences in the EDE Global Score or most secondary outcome measures at any time-point. Several baseline variables emerged as potential treatment effect moderators at EOT. Choosing between FBT…[Read more]

]]> 0 e8a7e39447e0a9753751cccc899793db Atkins posted an update: Selective amygdalohippocampectomy is an effective treatment […] http://www.nationalboardinstitute.com/activity/p/28692/ Tue, 28 Jan 2025 11:37:53 -0800 Selective amygdalohippocampectomy is an effective treatment for patients with therapy-refractory temporal lobe epilepsy but may cause visual field defect (VFD). Here, we aimed to describe tissue-specific pre- and postoperative imaging correlates of the VFD severity using whole-brain analyses from voxel- to network-level. Twenty-eight patients with…[Read more]

]]> 0 3649d761f6bbaf354f8291876b1dfa2d Atkins became a registered member http://www.nationalboardinstitute.com/activity/p/28555/ Tue, 28 Jan 2025 11:29:57 -0800 0